Explain to me why we invest so much money in research “Talent” then have huge misses like this? Add to this all the failed acquisitions, we would be better off acquiring companies with products already on the market.
https://www.bloomberg.com/news/arti...covid-pill-fumble-gives-pfizer-17-billion-win
Dean Li is obviously in way over his head. Early days in his tenure, the toilet already is overdue for flushing.
Did Junkyard Joe leave?
He is actually still here, reports to Rob Davis now with some “strategic” role between MMD and MRLDid Junkyard Joe leave?
Likely a brilliant scientist, but zero business acuity and poor leadership skills. Will be interesting to see how long his tenure lasts, chosen by Roger not Rob.Dean Li is obviously in way over his head. Early days in his tenure, the toilet already is overdue for flushing.
Likely a brilliant scientist, but zero business acuity and poor leadership skills. Will be interesting to see how long his tenure lasts, chosen by Roger not Rob.
Dean Li who is a founder of Recursion was hand picked by Junkyard Joe. Junkyard Joe was rewarded with a seat on the advisory board of Recursion.
One hand washes the other…..
Dean Li who is a founder of Recursion was hand picked by Junkyard Joe. Junkyard Joe was rewarded with a seat on the advisory board of Recursion.
One hand washes the other…..
He came over to Merck with Roger like 6-7 years ago, still here at 70+Are you referring to Joe Miletich? Why is he over at Merck now? I thought he was at Amgen.
He came over to Merck with Roger like 6-7 years ago, still here at 70+
